Jian Huang

Min Yang, Jian Huang, Jie Jin, 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner

Min Yang, Jian Huang, Jie Jin, 2008, Acta Pharmacologica Sinica.

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia

Y. Zhai, Jian Huang, Jiajia Pan, 2022, Journal of translational medicine.

Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study

Jian Huang, Xiaoqiong Zhu, Lan Zhang, 2022, Journal of Cancer Research and Clinical Oncology.

Next-Generation Sequencing Mutational Landscape and Clinical Features of Chinese Adults with Myeloproliferative Neoplasms

Jian Huang, Ke Jin, L. Zhang, 2021, Blood.

Prognostic utility of six mutated genes for older patients with acute myeloid leukemia

Jian Huang, Jie Jin, Qinrong Wang, 2018, International journal of cancer.

Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.

Jian Huang, Jie Jin, Zhongqi Li, 2020, Cancer biomarkers : section A of Disease markers.

Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms

Jian Huang, Xiaoqiong Zhu, Dan Chen, 2017, OncoTargets and therapy.

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

Jian Huang, Jie Jin, Jiajia Pan, 2020, Cancer biomarkers : section A of Disease markers.

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial.

Jianpeng Sheng, Min Yang, Jian Huang, 2022, The Lancet. Haematology.

Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy

Jian Huang, Jie Jin, Yungui Wang, 2013, Annals of Hematology.

Tigecycline and homoharringtonine synergistically target myeloid leukemia cells by inhibiting mitochondrial translation through mTOR/4EBP1 pathway

Jian Huang, Haiyang Yang, Hua Zhang, 2020 .

BCOR mutation and TLS-ERG expression in acute myeloid leukemia with monoclonal immunoglobulinemia

Jian Huang, Shuna Luo, Jingxia Jin, 2019, OncoTargets and therapy.

Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML

Jian Huang, Xiaoqiong Zhu, Jinghan Wang, 2020, Biomarker research.

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia

Jian Huang, Jie Jin, Jinghan Wang, 2019, Journal of Translational Medicine.

Decreased peripheral blood lymphocyte-monocyte ratio and platelet-monocyte ratio and the Peripheral Blood Score model predict poor survival in peripheral T-cell lymphoma patients

Jian Huang, Jie Jin, Qiu Fang, 2020 .

Prognostic impact of MYH9 expression on patients with acute myeloid leukemia

Jian Huang, Han-zhang Pan, Jie Jin, 2016, Oncotarget.

Successful treatment of a case of acute myeloid leukemia following Langerhans cell histiocytosis in an adolescent: a case report and review of the literature.

Min Yang, Jian Huang, Jie Jin, 2015, International journal of clinical and experimental medicine.

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

Jian Huang, Jie Jin, W. Qian, 2015, Leukemia & lymphoma.

A rare case of co-existent aggressive natural killer cell and acute monocytic leukemia with cytomegalovirus infection

Jian Huang, Jie Jin, Wenjing Zhou, 2008, International journal of hematology.

Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report

Jian Huang, Xiaofei Xu, Jingxia Jin, 2020, World journal of clinical cases.

Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR∷ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study

Jian Huang, Xiaoqiong Zhu, L. Zhang, 2022, Cancers.

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

Jian Huang, Jie Jin, W. Qian, 2008, Leukemia & lymphoma.

Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study

Jian Huang, Jie Jin, Jiajia Pan, 2021, Aging.

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma

Jian Huang, Y. Shao, Zhongqi Li, 2021, Frontiers in Oncology.

FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis

Jian Huang, Jiajia Pan, Chao Hu, 2023, Annals of Hematology.

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts

Jian Huang, Jie Jin, Yungui Wang, 2018, EBioMedicine.

[Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics].

Jian Huang, Jie Jin, Jing Chen, 2014, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins

Jian Huang, W. Qian, W. Xie, 2016, Oncotarget.

Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.

Jian Huang, Jie Jin, Yungui Wang, 2013, Leukemia research.

High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia.

Jian Huang, Jie Jin, W. Qian, 2013, Leukemia research.

Case Report: The First Report of NUP214-ABL1 Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing

Lin Wang, Jian Huang, Honghu Zhu, 2021, Frontiers in Oncology.

Antitumor activity of CDA-Ⅱ, a urinary preparation, on human multiple myeloma cell lines via the mitochondrial pathway.

Min Yang, Jian Huang, Jie Jin, 2014, Molecular medicine reports.

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

Jian Huang, Fengling Li, Hua-feng Wang, 2021, Experimental Hematology & Oncology.

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis

Jian Huang, Chao Hu, Shihui Mao, 2023, Journal of Translational Medicine.

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia

Jian Huang, Jie Jin, Yungui Wang, 2021, BMC Medicine.

MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.

Jian Huang, Dijiong Wu, B. Ye, 2017, American journal of translational research.

Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation

Min Yang, Jian Huang, Jie Jin, 2020, Thrombosis and Haemostasis.

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia

Jian Huang, Jie Jin, Jinghan Wang, 2019, Journal of Translational Medicine.

HAA方案治疗复发难治性急性髓系白血病64例疗效观察

Jian Huang, Jie Jin, W. Qian, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia

Jian Huang, Jie Jin, Xia Li, 2016, Oncotarget.

A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation

Jian Huang, J. Mao, X. Xi, 2018, Frontiers of Medicine.

The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population‐based study

Jian Huang, Xiaoqiong Zhu, Cai Wu, 2019, Hematological oncology.

Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis

Min Yang, Jian Huang, Yungui Wang, 2021, Frontiers of Medicine.

Abivertinib, a novel BTK inhibitor: anti-leukemia effects and synergistic efficacy with Homoharringtonine in acute myeloid leukemia.

Jian Huang, Yungui Wang, Jiajia Pan, 2019, Cancer letters.

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia

Jian Huang, Han-zhang Pan, Jie Jin, 2017, Scientific Reports.

Anaplastic large cell lymphoma presenting as an endobronchial polypoid mass

Jian Huang, Jie Jin, Lijun Wang, 2012, Leukemia & lymphoma.

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Wen-da Luo, Chun-Mei Chen, Jian Huang, 2021, Frontiers in Oncology.

Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma

Jian Huang, Jiajia Pan, Jinghan Wang, 2018, Journal of Cancer Research and Clinical Oncology.

Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases

Jian Huang, Jie Jin, W. Qian, 2016, Frontiers of Medicine.

Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.

Jian Huang, Han-zhang Pan, Jie Jin, 2015, Leukemia research.

Mining novel biomarkers for prognosis of gastric cancer with serum proteomics

F. Qiu, Jian Huang, Yi-ding Chen, 2009, Journal of experimental & clinical cancer research : CR.

MiR-15 a-5 p negatively regulates cell survival and metastasis by targeting CXCL 10 in chronic myeloid leukemia

Jian Huang, Dijiong Wu, B. Ye, 2017 .

Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up

Jian Huang, Xin Huang, Bin Li, 2020, Frontiers in Oncology.

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia

Xiao-jun Huang, Min Yang, Jian Huang, 2014, Journal of Hematology & Oncology.

Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients

Y. Li, Min Yang, Jian Huang, 2015, PloS one.

Long‐term efficacy of low‐dose all‐trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post‐remission therapy in newly diagnosed acute promyelocytic leukaemia

Jian Huang, Jie Jin, W. Qian, 2014, Hematological oncology.

Hyaline vascular Castleman disease associated with POEMS syndrome and cerebral infarction

Jian Huang, Jie Jin, Wenjing Zhou, 2006, Annals of Hematology.

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients

Jian Huang, H. Tong, W. Xie, 2023, Frontiers in Oncology.

Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression

Jian Huang, Chao Hu, Jinghan Wang, 2023, British journal of haematology.

ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification

Jian Huang, Yungui Wang, Jiajia Pan, 2023, Frontiers of Medicine.

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients

Min Yang, Jian Huang, Chao Hu, 2022, Frontiers in Oncology.

Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma

Min Yang, Jian Huang, Jie Jin, 2009, Leukemia & lymphoma.

Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy

Jian Huang, Jie Jin, W. Qian, 2014, Annals of Hematology.

Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia

Jian Huang, Jie Jin, W. Qian, 2015, Leukemia & lymphoma.

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

Jian Huang, Jie Jin, Yungui Wang, 2021, Journal of translational medicine.

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ITD

Jian Huang, Jiajia Pan, H. Tong, 2022, Molecular Oncology.

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

Jian Huang, J. Jin, J Jin, 2006, Leukemia.

[Efficacy and safety of the HAA regimen as induction chemotherapy in 236 de novo acute myeloid leukemia].

Jian Huang, Jie Jin, Fei-fei Chen, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms

Jian Huang, Jie Jin, Chao Hu, 2016, Leukemia & lymphoma.

Co-existence of myeloproliferative neoplasias and β-thalassemia with IVS-2-654 mutation—a case report

Jian Huang, Jie Jin, Cai Wu, 2020, Translational cancer research.